Side-by-side financials for CRBP and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRBP | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #49 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$78.54M | - |
| SEC filings | 781 | 1,004 |
Full pages: Corbus Pharmaceuticals Holdings, Inc. and AstraZeneca PLC, or browse the full rankings.